We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Array Technologies Inc | NASDAQ:ARRY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.345 | 2.80% | 12.685 | 12.68 | 12.69 | 12.86 | 12.285 | 12.38 | 2,469,553 | 19:27:00 |
From May 2019 to May 2024
BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Annual J.P. Morgan Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
|
Date: |
Wednesday, January 11, 2017 |
|
Time: |
8:30 a.m. Pacific Time |
|
Location: |
Westin St. Francis Hotel, San Francisco |
|
Webcast: |
http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22698 |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
|
thaugeto@arraybiopharma.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300377960.html
SOURCE Array BioPharma
Copyright 2017 PR Newswire
1 Year Array Technologies Chart |
1 Month Array Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
